New Products8 Feb 2022 14:19
I'm inclined to forget covid tests etc as regards MHC, it's great that they're still selling, and as we know they've made millions out of the sales. Not many companies on AIM have generated the cashflow that MHC have in such a short amount of time, however the market has not favoured MHC in this respect, nor has sentiment, which was heavily influenced by the media.
MHC are using their profits to develop their new products (I believe it's an April launch?), forget Covid, MHC is not about that. They're well placed, with excellent distribution/partners to make a significant impact in the home testing market, I'm very pleased they're also looking at an export market. They have the potential to be very big. Profit from Covid tests paid the bills, R&D, talent recruitment, app development etc., all good, and it may yet be the case that covid home testing increases (hope not), however MHC is now ready to prove what a well run (tiny mcap) company it is. The market will wake up. GLA